跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ceruloplasmin
首页
药物
Ceruloplasmin
Ceruloplasmin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTI-CERULOPLASMIN ANTIBODIES AND USES THEREOF
EP 4210751 A4
申请人: ALEXION PHARMA INC
优先权: 2020
EP
US
WO
5 件公开
METAL BINDING COMPOUNDS AND THEIR USE IN CELL CULTURE MEDIUM COMPOSITIONS
US 2008286868 A1
申请人: INVITROGEN CORP
优先权: 2000
US
4 件公开
Method of Treating Cancer Using Dithiocarbamate Derivatives
US 2007232692 A1
申请人: UNIV UTAH
优先权: 2000
US
4 件公开
US 6706759 B1
申请人: CHARLOTTE MECKLENBURG HOSPITAL
优先权: 2000
US
2 件公开
NUCLEIC ACID CONSTRUCTS AND GENE THERAPY VECTORS FOR USE IN THE TREATMENT OF WILSON DISEASE AND OTHER CONDITIONS
EP 3799889 A1
申请人: FUNDACION PARA LA INVESTIG MEDICA APLICADA
优先权: 2014
CN
EP
US
3 件公开
METHODS OF DETERMINING CERULOPLASMIN ACTIVITY AND APPLICATIONS THEREOF
EP 4540405 A1
申请人: ACADEMIA SINICA
优先权: 2022
EP
US
WO
3 件公开
NUCLEIC ACID CONSTRUCTS AND GENE THERAPY VECTORS FOR USE IN THE TREATMENT OF WILSON'S DISEASE AND OTHER CONDITIONS
EP 3744351 A1
申请人: FUNDACION PARA LA INVESTIG MEDICA APLICADA
优先权: 2014
EP
US
2 件公开
Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent
US 2002094949 A1
申请人: GESTILAB INC
优先权: 1999
US
2 件公开
Serum-free cell growth medium
US 2001039050 A1
申请人: LUYTEN FRANK P
优先权: 2001
US
2 件公开
Serum-derived factor inducing cell differentiation and medical uses thereof
US 2002054916 A1
申请人: PELED TONY
优先权: 2001
US
2 件公开
Kit and method of screening wilson's disease
US 7407743 B2
申请人: ZENOVAC INC KR
优先权: 2004
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈